Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency  | Penalty Amount |
|---|---|---|---|---|---|---|
| ZOETIS, LLC | Zoetis | pharmaceuticals | workplace safety or health violation | 2015 | OSHA | $7,140 |
| ZOETIS, LLC | Zoetis | pharmaceuticals | workplace safety or health violation | 2015 | OSHA | $14,700 |
| TEVA PHARMACEUTICAL USA, INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2016 | OSHA | $5,000 |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | Sun Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2016 | OSHA | $9,620 |
| AMNEAL PHARMACEUTICALS, LLC. | Amneal Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2016 | OSHA | $26,725 |
| SHIRE PLC | Takeda Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2016 | OSHA | $19,070 |
| IDEXX DISTRIBUTION, INC. | IDEXX Laboratories | pharmaceuticals | workplace safety or health violation | 2017 | OSHA | $9,600 |
| AMNEAL PHARMACEUTICALS, LLC | Amneal Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2017 | OSHA | $6,791 |
| ETHICON, INC. | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2017 | OSHA | $6,518 |
| DEPUY SYNTHES PRODUCTS, LLC | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2018 | OSHA | $5,654 |
| ALCAMI CORPORATION | Alcami | pharmaceuticals | workplace safety or health violation | 2018 | OSHA | $6,652 |
| JOHNSON & JOHNSON CONSUMER, INC. | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2018 | OSHA | $7,853 |
| SIGMA-ALDRICH | Merck KGaA (EMD) | pharmaceuticals | workplace safety or health violation | 2018 | OSHA | $23,632 |
| CAMBREX CHARLES CITY, INC. | Cambrex | pharmaceuticals | workplace safety or health violation | 2018 | OSHA | $18,000 |
| DEPUY SYNTHES | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $5,000 |
| TARO PHARMACEUTICALS USA, INC. | Sun Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $18,565 |
| CSL PLASMA | CSL Limited | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $15,422 |
| WOCKHARDT USA MORTON GROVE DBA MORTON GROVE PHARMACEUTICALS, INC. | Wockhardt Limited | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $7,900 |
| PHARMAVITE LLC | Otsuka Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $5,775 |
| GENERAL NUTRITION CORPORATION | Harbin Pharmaceutical Group | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $7,674 |
| ETHICON, INC. | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2020 | OSHA | $9,832 |
| HIKMA PHARMACEUTICALS | Hikma Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2020 | OSHA | $20,479 |
| AKORN OPERATING COMPANY, LLC | Akorn Inc. | pharmaceuticals | workplace safety or health violation | 2020 | OSHA | $13,653 |
| EMD MILLIPORE CORPORATION | Merck KGaA (EMD) | pharmaceuticals | workplace safety or health violation | 2021 | OSHA | $10,240 |
| PBM NUTRITIONALS LLC | Perrigo | pharmaceuticals | workplace safety or health violation | 2021 | OSHA | $14,502 |
| ROCHE MOLECULAR SYSTEMS, INC. | Roche | pharmaceuticals | workplace safety or health violation | 2021 | OSHA | $9,300 |
| MYLAN TECHNOLOGIES, INC. | Viatris | pharmaceuticals | workplace safety or health violation | 2021 | OSHA | $13,653 |
| GNC HOLDINGS LLC | Harbin Pharmaceutical Group | pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $6,720 |
| DEPUY SYNTHES PRODUCTS, INC. | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $7,044 |
| MODERNA, INC | Moderna Inc. | pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $6,000 |
| AMNEAL PHARMACEUTICALS | Amneal Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $6,250 |
| AMNEAL PHARMACEUTICALS, LLC | Amneal Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $8,439 |
| ULTRAGENYX PHARMACEUTICAL | Ultragenyx Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2023 | OSHA | $12,054 |
| GNC HOLDINGS INC. | Harbin Pharmaceutical Group | pharmaceuticals | workplace safety or health violation | 2023 | OSHA | $17,858 |
| IDEXX DISTRIBUTION, INC. | IDEXX Laboratories | pharmaceuticals | workplace safety or health violation | 2023 | OSHA | $32,245 |
| VERSUM MATERIALS | Merck KGaA (EMD) | pharmaceuticals | workplace safety or health violation | 2023 | OSHA | $8,438 |
| PERRIGO COMPANY PLC | Perrigo | pharmaceuticals | workplace safety or health violation | 2023 | OSHA | $12,600 |
| Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2008 | PA-AG | $6,950,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
| Dey Pharmaceuticals | Viatris | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
| TAP Pharmaceutical Products | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
| MUTUAL PHARMACEUTICAL CO INC | Sun Pharmaceuticals | pharmaceuticals | environmental violation | 2012 | PA-ENV | $8,500 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2016 | PA-ENV | $6,943 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2003 | PA-ENV | $8,978 |
| SANOFI PASTEUR | Sanofi | pharmaceuticals | environmental violation | 2006 | PA-ENV | $28,620 |
| SANOFI PASTEUR | Sanofi | pharmaceuticals | environmental violation | 2007 | PA-ENV | $6,400 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2016 | PA-ENV | $14,906 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2014 | PA-ENV | $12,270 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2009 | PA-ENV | $15,720 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2007 | PA-ENV | $12,565 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2006 | PA-ENV | $5,033,000 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2006 | PA-ENV | $194,000 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2005 | PA-ENV | $7,950 |
| MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2000 | PA-ENV | $15,086 |
| GLAXOSMITHKLINE LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2016 | PA-ENV | $5,259 |
| PHIBRO-TECH, INC | Phibro Animal Health | pharmaceuticals | hazardous waste violation | 2011 | SC-ENV | $15,000 |
| PHIBRO-TECH | Phibro Animal Health | pharmaceuticals | air pollution violation | 2004 | SC-ENV | $7,500 |
| Biovail Corporation | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
| Elan Corporation, plc | Perrigo | pharmaceuticals | accounting fraud or deficiencies | 2005 | SEC | $15,000,000 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
| Schering-Plough Corporation | Merck | pharmaceuticals | investor protection violation | 2003 | SEC | $1,000,000 |
| ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2002 | SEC | $1,000,000 |
| AstraZeneca PLC | AstraZeneca | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $5,522,000 |
| GlaxoSmithKline plc | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $20,000,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | investor protection violation | 2017 | SEC | $15,000,000 |
| Galena Biopharma, Inc. | SELLAS Life Sciences Group | pharmaceuticals | accounting fraud or deficiencies | 2017 | SEC | $200,000 |
| Alere Inc. | Abbott Laboratories | pharmaceuticals | accounting fraud or deficiencies | 2017 | SEC | $13,023,885 |
| Aegerion Pharmaceuticals | Amryt Pharma | pharmaceuticals | investor protection violation | 2017 | SEC | $4,100,000 |
| Cytrx Corporation | CytRx | pharmaceuticals | investor protection violation | 2017 | SEC | $75,000 |
| Clovis Oncology Inc. | Clovis Oncology | pharmaceuticals | investor protection violation | 2018 | SEC | $20,000,000 |
| Mylan N.V. | Viatris | pharmaceuticals | investor protection violation | 2019 | SEC | $30,000,000 |
| Amyris, Inc. | Amyris | pharmaceuticals | investor protection violation | 2021 | SEC | $300,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2008 | TX-AG | $28,000,000 |
| Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
| Boehringer Ingelheim Corp. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
| Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
| Endo Pharmaceuticals | Endo International | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
| Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
| Glenmark Generics Inc. | Glenmark Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
| Mylan Laboratories Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
| Novartis Pharmaceuticals | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
| Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
| Purdue Frederick Co. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2008 | TX-AG | $1,600,000 |
| Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
| Schering-Plough Corp. | Merck | pharmaceuticals | False Claims Act and related | 2004 | TX-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000 |
| SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
| Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
| Watson/Schein Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
| Lupin Pharmaceuticals, Inc. | Lupin Limited | pharmaceuticals | False Claims Act and related | 2019 | TX-AG | $63,000,000 |
| Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | pharmaceuticals | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
| Novartis Pharmaceuticals | Novartis | pharmaceuticals | kickbacks and bribery | 2015 | USAO | $390,000,000 |
| Mallinckrodt LLC | Mallinckrodt | pharmaceuticals | False Claims Act and related | 2013 | USAO | $3,500,000 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | USAO | $410,000,000 |
| Novo Nordisk Inc. | Novo Holdings A/S | pharmaceuticals | False Claims Act and related | 2011 | USAO | $1,725,000 |
| Synthes Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | USAO | $149,000,000 |
| Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | Controlled Substances Act violation | 2008 | USAO | $511,000 |
| Pharmacia & Upjohn Company Inc. | Pfizer | pharmaceuticals | kickbacks and bribery | 2007 | USAO | $19,700,000 |
| Pharmacia & Upjohn Company LLC | Pfizer | pharmaceuticals | kickbacks and bribery | 2007 | USAO | $15,000,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | fraud | 2005 | USAO | $300,000,000 |
